EUVIMEDEUVIMED entdecken
Open Access

Common drugs, vitamins, nutritional supplements and COVID‑19 mortality

Steven Lehrer, Peter H Rheinstein

International Journal of Functional Nutrition · 2021

DOI: 10.3892/ijfn.2021.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Functional Nutrition, 2021. Verfasst von Steven Lehrer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FDA has approved only one drug, remdesivir, for the treatment of COVID-19. The FDA has granted an emergency use authorization for the rheumatoid arthritis treatment drug, baricitinib (Olumiant), for the treatment of COVID-19 in some cases. For this reason, investigators have paid considerable attention to the association between commonly used drugs and the outcome of patients with COVID-19. Aspirin and ibuprofen have been reported to reduce the mortality rate. Omeprazole can increase mortality. In addition, some studies have demonstrated that famotidine diminishes mortality, while others have indicated that famotidine leads to a poorer prognosis. The present study used UK Biobank (UKB) data to assess the association of commonly used drugs with COVID-19 mortality. Data processing was performed on Minerva, a Linux mainframe with Centos 7.6. The UK Biobank Data Parser (ukbb_parser) was used, a python-based package that allows easy interfacing with the large UK Biobank dataset. The results revealed that aspirin and omeprazole were associated with an elevated mortality rate. Ibuprofen-related mortality was lower than laxative-related mortality. Aspirin users were also significantly older than other subjects. The association with mortality of cholesterol-lowering medications, blood pressure-lowering medications, hormone replacement and oral contraceptives in 134 female subjects revealed insignificant variability. The association of nutritional supplements in 238 subjects with mortality indicated that variability was insignificant. The lower mortality linked to the supplementation of vitamin D and vitamin B, presumably B complex, has been previously observed. On the whole, the present study demonstrates that although some of the associations described among drugs and COVID-19 are not novel, the utility of a new source, UKB, may prove to be useful in further examining these associations.

Schlagwörter

Stichwörter der Autor:innen

COVID-19drugsmortality

Autor:innen und Institutionen

  • Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Severn Health Solutions, Severna Park, MD 21146, USA.

Förderung

  • Medical Research Council
  • NCI NIH HHS
  • NIH HHS

Zitieren

APA

Lehrer, S., & Rheinstein, P. H. (2021). Common drugs, vitamins, nutritional supplements and COVID‑19 mortality. International Journal of Functional Nutrition. https://doi.org/10.3892/ijfn.2021.14

Vancouver

Lehrer S, Rheinstein PH. Common drugs, vitamins, nutritional supplements and COVID‑19 mortality. International Journal of Functional Nutrition. 2021. doi:10.3892/ijfn.2021.14

BibTeX
@article{Lehrer2021,
  author = {Lehrer, Steven and Rheinstein, Peter H},
  title = {Common drugs, vitamins, nutritional supplements and COVID‑19 mortality},
  journal = {International Journal of Functional Nutrition},
  year = {2021},
  doi = {10.3892/ijfn.2021.14}
}
Kostenlos starten →